Stockholders' Equity Attributable to Parent of Alzamend Neuro, Inc. from 30 Apr 2019 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Alzamend Neuro, Inc. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 30 Apr 2019 to 31 Jan 2026.
  • Alzamend Neuro, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Jan 2026 was $2,184,505, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,184,505 -$1,265,278 -37% 31 Jan 2026 10-Q 11 Mar 2026 2026 Q3
Q3 2025 $4,374,196 +$621,228 +17% 31 Oct 2025 10-Q 11 Mar 2026 2026 Q3
Q2 2025 $5,343,440 +$6,555,759 31 Jul 2025 10-Q 09 Dec 2025 2026 Q2
Q1 2025 $3,968,222 +$6,562,407 30 Apr 2025 10-Q 11 Mar 2026 2026 Q3
Q4 2024 $3,449,783 +$7,713,604 31 Jan 2025 10-Q 11 Mar 2026 2026 Q3
Q3 2024 $3,752,968 +$6,435,461 31 Oct 2024 10-Q 11 Mar 2026 2026 Q3
Q2 2024 $1,212,319 -$1,099,436 -974% 31 Jul 2024 10-Q 09 Dec 2025 2026 Q2
Q1 2024 $2,594,185 -$5,639,688 -185% 30 Apr 2024 10-Q 11 Mar 2026 2026 Q3
Q4 2023 $4,263,821 -$10,123,326 -173% 31 Jan 2024 10-Q 25 Mar 2024 2024 Q3
Q3 2023 $2,682,493 -$11,469,916 -131% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q2
Q2 2023 $112,883 -$11,294,658 -101% 31 Jul 2023 10-Q 15 Dec 2023 2024 Q2
Q1 2023 $3,045,503 -$10,306,008 -77% 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q4 2022 $5,859,505 -$6,102,634 -51% 31 Jan 2023 10-Q 15 Mar 2023 2023 Q3
Q3 2022 $8,787,423 -$4,237,988 -33% 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 $11,181,775 -$4,162,481 -27% 31 Jul 2022 10-Q 15 Dec 2023 2024 Q2
Q1 2022 $13,351,511 +$11,338,564 +563% 30 Apr 2022 10-Q 15 Dec 2023 2024 Q2
Q4 2021 $11,962,139 +$13,258,086 31 Jan 2022 10-Q 15 Mar 2023 2023 Q3
Q3 2021 $13,025,411 +$13,692,179 31 Oct 2021 10-Q 15 Mar 2023 2023 Q3
Q2 2021 $15,344,256 +$15,318,388 +59218% 31 Jul 2021 10-Q 12 Dec 2022 2022 Q2
Q1 2021 $2,012,947 +$1,191,238 +145% 30 Apr 2021 10-K 27 Jul 2023 2023 FY
Q4 2020 $1,295,947 31 Jan 2021 10-Q 15 Mar 2022 2022 Q3
Q3 2020 $666,768 31 Oct 2020 10-Q 15 Mar 2022 2022 Q3
Q2 2020 $25,868 31 Jul 2020 10-Q 13 Dec 2021 2022 Q2
Q1 2020 $821,709 +$504,794 +159% 30 Apr 2020 10-K 19 Jul 2022 2022 FY
Q1 2019 $316,915 30 Apr 2019 10-K 29 Jul 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.